Julia Aijun Wang
CIK 1860279 · Chief Financial Officer, EVP · last filed 2026-02-13
Julia Aijun Wang is a Chief Financial Officer, EVP who has filed 21 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for LH, was dated Feb 13, 2026. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $548.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$548.9K
2
21
-$1.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LH | Chief Financial Officer, EVP | 2,062 | $266.16 | $548.9K | $0 | 6 | 2026-02-13 |
| BeOne Medicines Ltd. (BGNE) Delisted | Chief Financial Officer | 0 | $184.71 | $0 | -$1.00M | 15 | 2024-07-03 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-13 | LH | Mixed | +615 | -$71.0K | EDGAR |
| 2026-02-12 | LH | Grant (A) | — | $0 | EDGAR |
| 2026-02-10 | LH | Mixed | +639 | -$70.4K | EDGAR |
| 2025-02-13 | LH | Grant (A) | — | $0 | EDGAR |
| 2025-02-10 | LH | Mixed | +557 | -$83.2K | EDGAR |
| 2024-12-04 | LH | Grant (A) | — | $0 | EDGAR |
| 2024-07-03 | BeOne Medicines Ltd. (BGNE) Delisted | Sell (S) | −472 | -$67.9K | EDGAR |
| 2024-06-26 | BeOne Medicines Ltd. (BGNE) Delisted | Sell (S) | −899 | -$139.9K | EDGAR |
| 2024-06-20 | BeOne Medicines Ltd. (BGNE) Delisted | Sell (S) | −916 | -$145.7K | EDGAR |
| 2024-06-07 | BeOne Medicines Ltd. (BGNE) Delisted | Grant (A) | +136,240 | $0 | EDGAR |